subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630

object_name: Stage I Pancreatic Cancer AJCC v8

tested_intervention: unsure


subject: CHEBI:15640

subject_name: Leucovorin

object_name: Stage 0 Pancreatic Cancer AJCC v8


subject: CHEBI:15640


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:6541

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:6541

object_name: pancreatic adenocarcinoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: retinitis pigmentosa

tested_intervention: yes


subject: UNII:15C2VL427D

object_name: retinitis pigmentosa 1


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: arthropathy


subject: UMLS:C4086546

object_name: Closed fracture proximal humerus, four part


subject: UMLS:C4086546

object_name: osteoarthritis


subject: UMLS:C4287749

subject_name: Onvatilimab

object_name: Childhood Solid Neoplasm


subject: UMLS:C4287749

object_name: Adult Solid Neoplasm


subject: UMLS:C4287749

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: generalized vitiligo


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:231679

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Inflammatory carcinoma of breast recurrent


subject: CHEBI:231679

object_name: Inflammatory carcinoma of breast stage IV


subject: CHEBI:231679

object_name: HER2/Neu Negative


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C5907961

subject_name: Fc-VEGFR1 Fusion Protein PB101

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5907961


subject: UMLS:C5907961


subject: UMLS:C5907961


subject: UMLS:C5907961

object_name: metastatic colorectal cancer


subject: UMLS:C5907961

object_name: liver carcinoma


subject: UMLS:C5907961

object_name: Stomach cancer


subject: UMLS:C5907961

object_name: gastric cancer


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: inborn mitochondrial myopathy


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: gastric ulcer


subject: PUBCHEM.COMPOUND:6096882

object_name: obesity due to congenital leptin deficiency


subject: PUBCHEM.COMPOUND:6096882

object_name: obesity due to leptin receptor gene deficiency


subject: PUBCHEM.COMPOUND:6096882

object_name: morbid obesity


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: CHEBI:6954

subject_name: Mitotane

object_name: prostate carcinoma


subject: CHEBI:6954

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:66586232

object_name: staphylococcal infection


subject: CHEBI:3614

subject_name: Chlorhexidine


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: Hemorrhage


subject: UMLS:C5690388

object_name: MELAS syndrome


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: abscess


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UMLS:C1541591

subject_name: omburtamab I-131

object_name: diffuse intrinsic pontine glioma


subject: UMLS:C0037668

subject_name: Somatotropin-Releasing Hormone

object_name: HIV lipodystrophy


subject: CHEBI:37845

subject_name: growth hormone


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: PR:000007968

subject_name: somatotropin


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: Stage III Rectal Cancer AJCC v6


subject: UNII:K16AIQ8CTM

object_name: Stage III Rectal Cancer AJCC v8


subject: UNII:K16AIQ8CTM

object_name: Stage IV Rectal Cancer AJCC v8


subject: UNII:K16AIQ8CTM

object_name: Rectal cancer stage IV


subject: UNII:K16AIQ8CTM

object_name: Stage IV Rectal Cancer AJCC v6


subject: UNII:K16AIQ8CTM

object_name: Stage III Colon Cancer AJCC v8


subject: UNII:K16AIQ8CTM

object_name: Stage III Colon Cancer


subject: UNII:K16AIQ8CTM

object_name: Stage IV Colon Cancer AJCC v8


subject: UNII:K16AIQ8CTM

object_name: Stage IV Colon Cancer AJCC v6


subject: UNII:K16AIQ8CTM

object_name: Malignant neoplasm of colon stage IV


subject: UNII:D1LXQ45S1O

subject_name: Cerdulatinib

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX

object_name: neoplasm of esophagus


subject: PUBCHEM.COMPOUND:52943456

object_name: lung neoplasm


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:61033


subject: UMLS:C5848169

subject_name: Nadroparin Calcium

object_name: venous thromboembolism


subject: UMLS:C5848169

object_name: thrombophilia due to thrombin defect


subject: UMLS:C5848169


subject: UMLS:C5848169


subject: UNII:LIA7Z4002P

subject_name: Nadroparin


subject: UNII:LIA7Z4002P


subject: UNII:LIA7Z4002P


subject: UNII:LIA7Z4002P


subject: UNII:C88817F47Y

object_name: metastatic prostate carcinoma


subject: UMLS:C1615019

object_name: Alzheimer disease type 1


subject: UMLS:C1615019

object_name: Alzheimer disease


subject: UMLS:C1615019

object_name: Parkinson disease


subject: UMLS:C1615019

object_name: multiple sclerosis


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: leukemia


subject: CHEBI:168243

object_name: childhood leukemia


subject: CHEBI:168243

object_name: adult lymphoma


subject: CHEBI:168243

object_name: lymphoma


subject: CHEBI:168243

object_name: pediatric lymphoma


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:39867


subject: CHEBI:8863

subject_name: Riluzole

object_name: bipolar disorder


subject: CHEBI:8863

object_name: bipolar depression


subject: CHEBI:30145

subject_name: lithium atom

object_name: progressive supranuclear palsy


subject: CHEBI:30145

object_name: corticobasal degeneration disorder


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: UNII:L2N7Z24B30


subject: CHEBI:49713

subject_name: Lithium cation


subject: CHEBI:49713


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C3540800


subject: PUBCHEM.COMPOUND:49849451

subject_name: Anacetrapib

object_name: inherited lipid metabolism disorder


subject: PUBCHEM.COMPOUND:49849451

object_name: Dyslipidemia


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Severe Sepsis


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Chronic right-sided heart failure


subject: CHEBI:9241

object_name: Right ventricular cardiomyopathy


subject: CHEBI:9241

object_name: pulmonary hypertension, primary, 4


subject: CHEBI:9241

object_name: pulmonary hypertension, primary, 3


subject: CHEBI:9241

object_name: pulmonary hypertension, primary, 2


subject: CHEBI:182618

subject_name: Methylone

object_name: post-traumatic stress disorder


subject: PR:000011383

subject_name: neuronal pentraxin-2

object_name: Pain, Intractable


subject: PR:000011383

object_name: neoplasm


subject: UMLS:C2698699


subject: UMLS:C2698699


subject: CHEBI:44185

subject_name: Methotrexate

object_name: Vasodilation disorder


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Hypercatabolism


subject: CHEBI:4466

object_name: Hypermetabolism


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:229658

subject_name: Perfluorohexyloctane

object_name: dry eye syndrome


subject: CHEBI:80308

subject_name: substance P

object_name: HER2 positive breast carcinoma


subject: CHEBI:80308

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:80308

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:80308

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:80308

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:80308

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:80308

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:80308

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:80308

object_name: breast adenocarcinoma


subject: UNII:PY79D6C8RX

subject_name: Crofelemer


subject: UNII:PY79D6C8RX


subject: UNII:PY79D6C8RX


subject: UNII:PY79D6C8RX


subject: UNII:PY79D6C8RX


subject: UNII:PY79D6C8RX


subject: UNII:PY79D6C8RX


subject: UNII:PY79D6C8RX


subject: UNII:PY79D6C8RX


subject: CHEBI:4534

subject_name: Difenoxin


subject: CHEBI:4534


subject: CHEBI:4534


subject: CHEBI:4534


subject: CHEBI:4534


subject: CHEBI:4534


subject: CHEBI:4534


subject: CHEBI:4534


subject: CHEBI:4534


subject: CHEBI:4639

subject_name: Diphenoxylate


subject: CHEBI:4639


subject: CHEBI:4639


subject: CHEBI:4639


subject: CHEBI:4639


subject: CHEBI:4639


subject: CHEBI:4639


subject: CHEBI:4639


subject: CHEBI:4639


subject: CHEBI:57858

subject_name: atropinium


subject: CHEBI:57858


subject: CHEBI:57858


subject: CHEBI:57858


subject: CHEBI:57858


subject: CHEBI:57858


subject: CHEBI:57858


subject: CHEBI:57858


subject: CHEBI:57858


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:92712


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: UMLS:C1161352


subject: UMLS:C1161352


subject: UMLS:C1161352


subject: UMLS:C1161352


subject: UMLS:C1161352


subject: UMLS:C1161352


subject: UMLS:C1161352


subject: UMLS:C1161352


subject: CHEBI:6532

subject_name: Loperamide


subject: CHEBI:6532


subject: CHEBI:6532


subject: CHEBI:6532


subject: CHEBI:6532


subject: CHEBI:6532


subject: CHEBI:6532


subject: CHEBI:6532


subject: CHEBI:6532


subject: CHEBI:61397

subject_name: Neratinib


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:25357

subject_name: mitomycin

object_name: corneal disease


subject: CHEBI:27504

subject_name: Mitomycin


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Netherton syndrome


subject: CHEBI:45285

subject_name: Pyrazinamide

object_name: pulmonary tuberculosis


subject: CHEBI:2639

subject_name: Amiloride

object_name: Prehypertension


subject: PUBCHEM.COMPOUND:156501355

object_name: lung cancer


subject: PUBCHEM.COMPOUND:156501355

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:156501355

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:156501355

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:156501355

object_name: lung neoplasm


subject: UMLS:C4528574

subject_name: PTPN11 inhibitor TNO155


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:19231

object_name: follicular lymphoma


subject: CHEBI:33394

subject_name: fermium


subject: CHEBI:190709

subject_name: Phe-Met


subject: PR:000007579

subject_name: fibromodulin


subject: PUBCHEM.COMPOUND:92002593

subject_name: Ibritumomab


subject: UNII:4Q52C550XK

subject_name: Ibritumomab tiuxetan


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: heart failure


subject: CHEBI:81579

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:66586232

object_name: Surgical Wound Infection


subject: CHEBI:7025

subject_name: Mupirocin


subject: UMLS:C4733221

subject_name: L-tryptophan/thymine-based supplement

object_name: cancer


subject: UMLS:C4733221

object_name: neoplasm


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Advanced Cholangiocarcinoma


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:5470

subject_name: tibolone

object_name: Menopause present (finding)


subject: PUBCHEM.COMPOUND:5470

object_name: Menopause


subject: UMLS:C0982294

subject_name: nux vomica extract

object_name: atrial fibrillation


subject: UMLS:C0982294

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C0982294

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:137359

object_name: Control of hip fracture risk


subject: CHEBI:137359

object_name: hip fracture


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid


subject: CHEBI:37084


subject: CHEMBL.COMPOUND:CHEMBL4525124

subject_name: HMB


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: CHEBI:89324


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UNII:CR743OME9E

object_name: rheumatoid arthritis


subject: CHEBI:59030

subject_name: Oleandrin

object_name: lung cancer


subject: CHEBI:59030

object_name: lung neoplasm


subject: CHEBI:59030

object_name: lung carcinoma


subject: CHEBI:59030

object_name: Chemotherapeutic Agent Toxicity


subject: MESH:C430926

subject_name: Anvirzel


subject: MESH:C430926


subject: MESH:C430926


subject: MESH:C430926


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:176724

subject_name: Etiracetam

object_name: severe pre-eclampsia


subject: CHEBI:176724

object_name: preeclampsia and eclampsia


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: UNII:73HC18Y1LW


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:6437


subject: CHEBI:231679

subject_name: ipilimumab

object_name: atypical teratoid rhabdoid tumor


subject: CHEBI:231679

object_name: Childhood Atypical Teratoid/Rhabdoid Tumor


subject: CHEBI:231679

object_name: rhabdoid tumor of the kidney


subject: CHEBI:231679

object_name: rhabdoid tumor


subject: CHEBI:231679

object_name: epithelioid sarcoma


subject: CHEBI:231679

object_name: adult epithelioid sarcoma


subject: CHEBI:231679

object_name: childhood epithelioid sarcoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C3896920

subject_name: MDM2/MDMX Inhibitor ALRN-6924

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:86305217

subject_name: DALZANEMDOR

object_name: mild neurocognitive disorder


subject: PUBCHEM.COMPOUND:86305217

object_name: mild cognitive impairment


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Stomach cancer


subject: CHEBI:63605

object_name: gastric cancer


subject: CHEBI:63605

object_name: carcinoma of esophagus


subject: CHEBI:63605

object_name: esophageal cancer


subject: CHEBI:63605

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:63605

object_name: neoplasm of esophagus


subject: CHEBI:8427

subject_name: Probucol

object_name: diabetic kidney disease


subject: CHEBI:31401

subject_name: Cilostazol


subject: UMLS:C5544403

subject_name: Secretome

object_name: osteoarthritis, knee


subject: CHEBI:50858

subject_name: corticosteroid


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UMLS:C0592235

subject_name: Ursofalk

object_name: intrahepatic cholestasis of pregnancy


subject: CHEBI:9907

subject_name: ursodiol


subject: UMLS:C1330431

subject_name: NovoLOG FlexPen

object_name: type 1 diabetes mellitus 1


subject: UMLS:C1330431

object_name: type 1 diabetes mellitus


subject: UNII:MQ908Y1ZB2

object_name: endogenous depression


subject: UNII:MQ908Y1ZB2

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:173480

object_name: neuralgia


subject: PUBCHEM.COMPOUND:173480

object_name: Neuropathic pain


subject: UMLS:C3896652


subject: UMLS:C3896652


subject: UMLS:C1871984

object_name: Diabetic Neuralgia


subject: UMLS:C1871984

object_name: diabetic polyneuropathy


subject: UMLS:C1871984

object_name: Diabetic Mononeuropathy


subject: CHEBI:135966

subject_name: Carisbamate


subject: CHEBI:135966


subject: CHEBI:135966


subject: CHEBI:46058

subject_name: TAXOTERE

object_name: prostate carcinoma


subject: CHEBI:46058

object_name: prostate cancer


subject: UNII:MWI54OUA12

subject_name: Vercirnon

object_name: Crohn disease


subject: MESH:C583420


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: nasopharyngeal carcinoma


subject: GTOPDB:12966

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C4727210


subject: UMLS:C0304229

subject_name: Experimental drug

object_name: acne


subject: CHEBI:3357

subject_name: Cannabichromene

object_name: rheumatoid arthritis


subject: CHEBI:135207

subject_name: Clofedanol

object_name: hypertension, pregnancy-induced


subject: CHEBI:15365

subject_name: Aspirin


subject: PUBCHEM.COMPOUND:3367

object_name: systemic sclerosis


subject: CHEBI:86158

subject_name: calcium chloride dihydrate

object_name: Diastolic dysfunction


subject: CHEBI:3312

subject_name: Calol


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: congenital hypothyroidism


subject: CHEBI:18332

subject_name: Levothyroxine


subject: UMLS:C5565333

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C5239502

subject_name: Salovum

object_name: glioblastoma


subject: UMLS:C5239502

object_name: Childhood Glioblastoma


subject: UMLS:C5239502

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: acute renal disease


subject: CHEBI:2038

subject_name: Azacitidine


subject: UNII:41J7ZJ239R

object_name: cancer


subject: UNII:41J7ZJ239R

object_name: neoplasm


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: HIV infection


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:4FR53SIF3A

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:4FR53SIF3A

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: CHEBI:4305

subject_name: dacarbazine

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:4305

object_name: Stage I Adult Soft Tissue Sarcoma AJCC v7


subject: CHEBI:4305

object_name: Stage II Adult Soft Tissue Sarcoma AJCC v7


subject: CHEBI:4305

object_name: Stage III Adult Soft Tissue Sarcoma AJCC v7


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:74947


subject: CHEBI:74947


subject: CHEBI:74947


subject: UNII:H5212R2DPM

object_name: Myelodysplasia


subject: DRUGBANK:DB19210


subject: CHEBI:22586

subject_name: antioxidant

object_name: colorectal adenoma


subject: UMLS:C0003402

subject_name: Antioxidants


subject: MESH:C000624167

subject_name: Utrogestan

object_name: Gene Abnormality


subject: CHEBI:17026

subject_name: Progesterone


subject: PUBCHEM.COMPOUND:154677753

subject_name: famlasertib

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: PUBCHEM.COMPOUND:154677753

object_name: amyotrophic lateral sclerosis


subject: DRUGBANK:DB18649

subject_name: Prosetin


subject: DRUGBANK:DB18649


subject: CHEBI:50729

subject_name: Mitoxantrone

object_name: multiple sclerosis


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Anaesthesia intubation complication


subject: CHEBI:9130

object_name: Cardiac complication


subject: CHEBI:76018

subject_name: Riociguat

object_name: Heart failure with normal ejection fraction


subject: PUBCHEM.COMPOUND:169134691

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:169134691

object_name: Advanced breast cancer


subject: PUBCHEM.COMPOUND:169134691

object_name: Advanced lung cancer


subject: PUBCHEM.COMPOUND:169134691

object_name: ERBB2 mutation-related tumors


subject: PUBCHEM.COMPOUND:169134691

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:169134691

object_name: metastatic colorectal cancer


subject: PUBCHEM.COMPOUND:169134691

object_name: Secondary malignant neoplasm of lung


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox


subject: PUBCHEM.COMPOUND:135659064


subject: PUBCHEM.COMPOUND:135659064


subject: PUBCHEM.COMPOUND:135659064


subject: PUBCHEM.COMPOUND:135659064


subject: PUBCHEM.COMPOUND:135659064


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C2346822

subject_name: conatumumab

object_name: malignant soft tissue neoplasm


subject: UMLS:C2346822

object_name: sarcoma


subject: UMLS:C2346822

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C2346822

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C2346822

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C2346822

object_name: soft tissue sarcoma


subject: CHEBI:90881

subject_name: Camptosar

object_name: bladder tumor


subject: CHEBI:90881

object_name: urinary bladder carcinoma


subject: CHEBI:90881

object_name: urinary bladder cancer


subject: CHEBI:90881

object_name: childhood bladder carcinoma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:76003

subject_name: afatinib dimaleate

object_name: Pancreatic carcinoma stage IVA


subject: CHEBI:76003

object_name: Stage IVB Pancreatic Cancer


subject: CHEBI:76003

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:76003

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:76003

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:76003

object_name: Recurrent Malignant Solid Neoplasm


subject: CHEBI:76003

object_name: bile duct carcinoma


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:91400

subject_name: Afatinib


subject: CHEBI:91400


subject: CHEBI:91400


subject: CHEBI:91400


subject: CHEBI:91400


subject: CHEBI:91400


subject: CHEBI:91400


subject: CHEBI:44915

subject_name: Propofol

object_name: pregnancy disorder


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Advanced breast cancer


subject: CHEBI:4445

subject_name: Desflurane

object_name: Ambulation Difficulty


subject: CHEBI:4445

object_name: urinary system disorder


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:28680

subject_name: Cytarabine


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:PVI5M0M1GW

object_name: Refractory Myelodysplastic Syndrome


subject: UNII:PVI5M0M1GW

object_name: Recurrent Myelodysplastic Syndrome


subject: UNII:PVI5M0M1GW

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib


subject: PUBCHEM.COMPOUND:78140854


subject: PUBCHEM.COMPOUND:78140854


subject: PUBCHEM.COMPOUND:78140854


subject: CHEBI:73611

subject_name: Met-Gly

object_name: Relapse multiple myeloma


subject: CHEBI:73611

object_name: Plasma cell myeloma recurrent


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: UNII:1351PE5UGS

subject_name: Elotuzumab


subject: GTOPDB:4931

subject_name: flagellin

object_name: plague


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: cervical adenosquamous carcinoma


subject: CHEBI:45863

object_name: Cervical Squamous Cell Carcinoma, Not Otherwise Specified


subject: CHEBI:62880

subject_name: Veliparib

object_name: Cervix carcinoma recurrent


subject: CHEBI:62880

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: CHEBI:62880

object_name: cervical adenocarcinoma


subject: CHEBI:62880


subject: CHEBI:62880


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: proteinuria


subject: PUBCHEM.COMPOUND:24993045

object_name: Proteinuria of undiagnosed cause


subject: PUBCHEM.COMPOUND:24993045

object_name: Proteinuria, CTCAE 3.0


subject: PUBCHEM.COMPOUND:24993045

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C3529192


subject: UMLS:C3529192


subject: UMLS:C3529192


subject: UMLS:C3529192


subject: CHEBI:75431

subject_name: ghrelin

object_name: traumatic encephalopathy


subject: CHEBI:75431

object_name: traumatic brain injury


subject: CHEBI:75431

object_name: concussion


subject: DRUGBANK:DB11895

subject_name: Lenomorelin


subject: DRUGBANK:DB11895


subject: DRUGBANK:DB11895


subject: UMLS:C0911014


subject: UMLS:C0911014


subject: UMLS:C0911014


subject: UNII:2XOI31YC4N

subject_name: Pretomanid

object_name: tuberculosis


subject: UNII:3934EF02T7

subject_name: Piflufolastat F 18

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:3934EF02T7

object_name: castration-resistant prostate carcinoma


subject: CHEBI:48935

subject_name: roxithromycin

object_name: alopecia


subject: CHEBI:48935

object_name: Alopecia, CTCAE


subject: CHEBI:32109

subject_name: (Z)-roxithromycin


subject: CHEBI:32109


subject: UMLS:C5960009

subject_name: CD16-based ROR1-targeted NK Cell Engager PBA-0405

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5960009

object_name: triple-negative breast carcinoma


subject: UMLS:C5960009

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5960009

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Surgical procedure finding


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:8093

subject_name: Phenylephrine


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: neoplastic meningitis


subject: UNII:2S9ZZM9Q9V

object_name: Activating EGFR Gene Mutation


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:90943


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:15367

object_name: childhood myelodysplastic syndrome


subject: CHEBI:15367

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:50648


subject: CHEBI:50648


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Fractured tibia


subject: CHEBI:33376

subject_name: terbium atom


subject: CHEBI:35020

subject_name: Tributyrin


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: mortality


subject: PUBCHEM.COMPOUND:54675783

object_name: Morbidity


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: Metastatic castration-resistant prostate cancer


subject: PUBCHEM.COMPOUND:126481870

subject_name: valemetostat


subject: UNII:60RD0234VE

subject_name: Valemetostat


subject: CHEBI:7824

subject_name: Oxcarbazepine

object_name: Seizure Related to COVID-19


subject: CHEBI:7824

object_name: epilepsy


subject: CHEBI:7824

object_name: visual epilepsy


subject: CHEBI:32599

object_name: stroke disorder


subject: CHEBI:32599

object_name: cerebrovascular disorder


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Reperfusion Injury


subject: CHEBI:39548

object_name: disorder; heart, functional, postoperative, cardiac surgery


subject: CHEBI:39548

object_name: Cardiac insufficiency following cardiac surgery


subject: CHEBI:39548

object_name: atrial fibrillation


subject: CHEBI:39548

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:39548

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:4911

subject_name: Etoposide

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:58097

object_name: Renal Colic, CTCAE


subject: CHEBI:58097

object_name: renal colic


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEMBL.COMPOUND:CHEMBL4594340

subject_name: POSOLEUCEL

object_name: EBV Infection


subject: CHEMBL.COMPOUND:CHEMBL4594340

object_name: cytomegalovirus infection


subject: CHEMBL.COMPOUND:CHEMBL4594340

object_name: JC virus infection


subject: CHEMBL.COMPOUND:CHEMBL4594340

object_name: HHV6 Infection


subject: CHEBI:74820

subject_name: Ser-Pro

object_name: anemia


subject: CHEBI:74820

object_name: Anemia, CTCAE


subject: CHEBI:80308

subject_name: substance P


subject: CHEBI:80308


subject: PR:000016275

subject_name: trefoil factor 2


subject: PR:000016275


subject: UniProtKB:Q03404

subject_name: TFF2_MOUSE Trefoil factor 2 (sprot)


subject: UniProtKB:Q03404


subject: CHEBI:131327


subject: CHEBI:131327


subject: CHEBI:2674

subject_name: Amodiaquine


subject: CHEBI:2674


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:49900

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Prader-Willi syndrome


subject: CHEBI:31401

subject_name: Cilostazol

object_name: migraine with aura


subject: UNII:5ZHA5P4PFX

subject_name: Dalpiciclib

object_name: esophageal squamous cell carcinoma


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib


subject: CHEMBL.COMPOUND:CHEMBL2109352

object_name: leukemia


subject: CHEMBL.COMPOUND:CHEMBL2109352

object_name: childhood leukemia


subject: UNII:SE2KH7T06F

object_name: uterine corpus cancer


subject: UMLS:C4287766

object_name: endometrial cancer


subject: UMLS:C4287766


subject: UMLS:C4287766

object_name: endometrial carcinoma


subject: MESH:C555877

subject_name: Remaxol

object_name: cancer


subject: MESH:C555877

object_name: neoplasm


subject: MESH:C555877

object_name: drug-induced liver injury


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: Pre T-ALL


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: bipolar disorder


subject: UNII:B72HH48FLU

object_name: bipolar depression


subject: CHEBI:4911

subject_name: Etoposide

object_name: prostate carcinoma


subject: CHEBI:4911

object_name: prostate cancer


subject: CHEBI:9241

subject_name: Spironolactone

object_name: aneurysm


subject: CHEBI:9241

object_name: type 2 diabetes mellitus


subject: MESH:C000722781

subject_name: RVM-V001 COVID-19 vaccine


subject: MESH:C000722781

object_name: infectious disease


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: heart failure


subject: UMLS:C1881373

object_name: Heart Failure, CTCAE


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Mesothelioma


subject: UNII:M89N0Q7EQR

object_name: mesothelial neoplasm


subject: UNII:M89N0Q7EQR

object_name: malignant mesothelioma


subject: UNII:M89N0Q7EQR

object_name: ovarian carcinoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: lung cancer


subject: PUBCHEM.COMPOUND:3367

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:3367

object_name: lung carcinoma


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: heart disorder


subject: CHEBI:6801

subject_name: Metformin

object_name: systolic heart failure


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: ulcerative colitis


subject: CHEBI:30314

object_name: inflammatory bowel disease 1


subject: CHEBI:17460

subject_name: Thioctamide


subject: CHEBI:17460


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: UMLS:C5854467

subject_name: Anti-CD19/CD3 T-cell Engaging Bispecific Antibody CLN-978

object_name: SLE (systemic lupus)


subject: UMLS:C5854467

object_name: EXCESS LMW-DNA


subject: UMLS:C5854467

object_name: st. Louis encephalitis


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: acute myeloid leukemia


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UNII:M89N0Q7EQR


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: female reproductive system disorder


subject: CHEBI:60791

subject_name: Xylocard


subject: CHEBI:6456

subject_name: Lidocaine


subject: UMLS:C0038889

subject_name: Endogenous Surfactants

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: UMLS:C0038889

object_name: acute respiratory distress syndrome


subject: UMLS:C0038889

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: UMLS:C0038889

object_name: adult acute respiratory distress syndrome


subject: UMLS:C0038889

object_name: congenital alveolar dysplasia


subject: CHEBI:35195

subject_name: surfactant


subject: CHEBI:35195


subject: CHEBI:35195


subject: CHEBI:35195


subject: CHEBI:35195


subject: UMLS:C2825078

subject_name: Surfactant [EPC]


subject: UMLS:C2825078


subject: UMLS:C2825078


subject: UMLS:C2825078


subject: UMLS:C2825078


subject: CHEBI:27241

subject_name: methyl uridin-5-yloxyacetate


subject: CHEBI:27241


subject: CHEBI:27241


subject: CHEBI:27241


subject: CHEBI:27241


subject: CHEBI:27241

object_name: respiratory distress syndrome in premature infants


subject: CHEBI:27241

object_name: newborn respiratory distress syndrome


subject: CHEBI:73616

subject_name: Met-Val


subject: CHEBI:73616


subject: CHEBI:73616


subject: CHEBI:73616


subject: CHEBI:73616


subject: CHEBI:73616


subject: CHEBI:73616


subject: CHEBI:190738

subject_name: Demethylated antipyrine

object_name: Ischemic stroke


subject: UNII:S798V6YJRP

subject_name: EDARAVONE


subject: CHEBI:31530

subject_name: Edaravone


subject: PUBCHEM.COMPOUND:135483998

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:135402010


subject: CHEBI:136009

subject_name: L-Methylfolate


subject: CHEBI:49662

subject_name: Indomethacin

object_name: Ankle Sprains


subject: UMLS:C5704819

subject_name: Daxxify

object_name: Glabellar frown lines


subject: UMLS:C1121680

subject_name: TMC 125

object_name: Mycoses


subject: UMLS:C1121680

object_name: AIDS


subject: UNII:RJ1IW3B4QX

subject_name: Tezepelumab

object_name: Cardiovascular event


subject: RXCUI:1940699

subject_name: glecaprevir / pibrentasvir Oral Product

object_name: respiratory failure


subject: RXCUI:1940699

object_name: Respiratory Failure, CTCAE


subject: RXCUI:1940699

object_name: hepatitis C


subject: CHEBI:133008

subject_name: Epclusa


subject: CHEBI:133008


subject: RXCUI:1799208

subject_name: sofosbuvir / velpatasvir Oral Product


subject: RXCUI:1799208


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Endometrial Intraepithelial Neoplasia


subject: CHEBI:38545

object_name: atypical endometrial hyperplasia


subject: UMLS:C5139959

object_name: chronic obstructive pulmonary disease


subject: UNII:LMQ24G57E9

subject_name: Daridorexant


subject: MESH:C558471

subject_name: Hizentra


subject: UMLS:C2699335

subject_name: cixutumumab

object_name: non-small cell lung carcinoma


subject: UNII:2285XW22DR


subject: CHEBI:50693

subject_name: Milrinone

object_name: pulmonary hypertension


subject: CHEBI:50693

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: end stage renal failure


subject: CHEBI:6888

object_name: chronic kidney disease


subject: CHEBI:6888

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Heart failure with mid range ejection fraction


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Sinonasal Poorly Differentiated Carcinoma


subject: CHEBI:31355

object_name: Locally Advanced Sinonasal Squamous Cell Carcinoma


subject: CHEBI:31355

object_name: Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: CHEBI:31355

object_name: Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: CHEBI:31355

object_name: sinonasal undifferentiated carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:231416

subject_name: Danicopan


subject: CHEBI:231416

object_name: C3 glomerulonephritis


subject: CHEBI:231416

object_name: dense deposit disease


subject: CHEBI:195280

subject_name: Artemether

object_name: Plasmodium falciparum malaria


subject: PUBCHEM.COMPOUND:71300864

object_name: hypertension


subject: PUBCHEM.COMPOUND:71300864

object_name: Hypertension, CTCAE


subject: UMLS:C2933615

subject_name: LCZ 696


subject: UMLS:C2933615


subject: GTOPDB:4934

subject_name: G-CSF

object_name: Small cell lung cancer extensive stage


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:47781

subject_name: Desipramine

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:47781

object_name: Back pain


subject: CHEBI:47781

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Recurrent tumor


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:132922

object_name: Fractured tibia


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Sex Characteristics


subject: CHEBI:2704

object_name: Cerebral Blood Flow


subject: CHEBI:2704

object_name: Pulmonary (intended site)


subject: CHEBI:2704

object_name: Adverse Event Associated with the Vascular System


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: CHEBI:23965


subject: CHEBI:23965


subject: PR:000015454

subject_name: sperm-associated antigen 11B


subject: PR:000015454


subject: PR:000015454


subject: PR:000015454


subject: PR:000022039

subject_name: dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex


subject: PR:000022039


subject: PR:000022039


subject: PR:000022039


subject: PR:000015453

subject_name: sperm-associated antigen 11A


subject: PR:000015453


subject: PR:000015453


subject: PR:000015453


subject: UMLS:C1268855

subject_name: Gonadotropin releasing hormone antagonist


subject: UMLS:C1268855


subject: UMLS:C1268855


subject: UMLS:C1268855


subject: UMLS:C3537040

subject_name: Gonadotropin Releasing Hormone Antagonist [EPC]


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: CHEBI:84094


subject: CHEBI:84094


subject: CHEBI:84094


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: UMLS:C4721537


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: CHEBI:17347


subject: CHEBI:17347


subject: UNII:S7H48S6K7H

subject_name: Troriluzole

object_name: melanoma


subject: UNII:S7H48S6K7H

object_name: metastatic melanoma


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: mucocutaneous lymph node syndrome


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB

object_name: Solid Neoplasm


subject: UMLS:C4331912


subject: CHEBI:63918

subject_name: Artesunate

object_name: infertility


subject: CHEBI:63918

object_name: infertility tubal factor


subject: CHEBI:63918

object_name: tubal factor infertility


subject: CHEBI:63918

object_name: Chlamydia trachomatis infection


subject: CHEBI:18231

subject_name: arsenic acid


subject: CHEBI:18231


subject: CHEBI:18231


subject: CHEBI:18231


subject: UniProtKB:P0AF61

subject_name: GHOS_ECOLI Endoribonuclease antitoxin GhoS (sprot)


subject: UniProtKB:P0AF61


subject: UniProtKB:P0AF61


subject: UniProtKB:P0AF61


subject: PR:000002156


subject: PR:000002156


subject: PR:000002156


subject: PR:000002156


subject: PR:000006315

subject_name: protein artemis


subject: PR:000006315


subject: PR:000006315


subject: PR:000006315


subject: PR:000003846

subject_name: agouti-related protein


subject: PR:000003846


subject: PR:000003846


subject: PR:000003846


subject: UMLS:C3897258

subject_name: Ubidecarenone Nanodispersion BPM31510n

object_name: pancreatic neoplasm


subject: UMLS:C3897258

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3897258

object_name: malignant pancreatic neoplasm


subject: CHEBI:6843

subject_name: Methoxyflurane

object_name: benign prostatic hyperplasia


subject: UMLS:C4552025

subject_name: Thymidine Kinase (-) Vaccinia-GM-CSF JX-594 Vaccine

object_name: colorectal carcinoma


subject: CHEBI:6121

subject_name: Ketamine

object_name: Maternity blues


subject: DRUGBANK:DB06184

object_name: Advanced cancer


subject: CHEBI:78543

subject_name: Ponatinib

object_name: Philadelphia positive


subject: CHEBI:9649

subject_name: Trandolapril

object_name: hypertension


subject: CHEBI:9649

object_name: Hypertension, CTCAE


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin

object_name: Adverse effects in the therapeutic use of anticoagulants


subject: UNII:8NZ41MIK1O

object_name: Poisoning by, adverse effect of and underdosing of anticoagulants


subject: UNII:8NZ41MIK1O

object_name: Poisoning by anticoagulant


subject: UNII:8NZ41MIK1O

object_name: high-risk pregnancy


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: carpal tunnel syndrome 1


subject: CHEBI:30314

object_name: carpal tunnel syndrome


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered

object_name: Hodgkin Disease


subject: UMLS:C0919144

object_name: Myelodysplasia


subject: UMLS:C0919144

object_name: Myelodysplasia, CTCAE


subject: UMLS:C0919144

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C0919144

object_name: acute myeloid leukemia


subject: UMLS:C0919144

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C0919144

object_name: acute lymphoblastic leukemia


subject: UMLS:C0919144

object_name: paroxysmal nocturnal hemoglobinuria


subject: UMLS:C0919144

object_name: plasma cell myeloma


subject: UMLS:C0919144

object_name: myelofibrosis


subject: UMLS:C0919144

object_name: non-Hodgkin lymphoma


subject: UMLS:C0919144

object_name: aplastic anemia


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: UNII:9927MT646M


subject: CHEBI:8988

object_name: Stage II Rectal Cancer AJCC v8


subject: CHEBI:8988

object_name: Locally Advanced Rectal Carcinoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: Childhood Breast Carcinoma


subject: CHEBI:90001

object_name: breast carcinoma


subject: CHEBI:90001

object_name: breast cancer


subject: CHEBI:90001

object_name: Cyclosporine toxicity


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: PR:000050337


subject: PR:000050337


subject: CHEBI:2376

subject_name: acarbose

object_name: Surgical procedure finding


subject: CHEBI:2376

object_name: hypoglycemia


subject: CHEBI:2376

object_name: Blood glucose below reference range (finding)


subject: CHEBI:2376

object_name: Hypoglycemia, CTCAE


subject: CHEBI:2376

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:2376

object_name: obesity


subject: CHEBI:2376

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:4432690

subject_name: Alpha-Acarbose


subject: PUBCHEM.COMPOUND:4432690


subject: PUBCHEM.COMPOUND:4432690


subject: PUBCHEM.COMPOUND:4432690


subject: PUBCHEM.COMPOUND:4432690


subject: PUBCHEM.COMPOUND:4432690


subject: PUBCHEM.COMPOUND:4432690


subject: UMLS:C4082329

subject_name: Glucobay


subject: UMLS:C4082329


subject: UMLS:C4082329


subject: UMLS:C4082329


subject: UMLS:C4082329


subject: UMLS:C4082329


subject: UMLS:C4082329


subject: CHEBI:84363


subject: CHEBI:84363


subject: CHEBI:84363


subject: CHEBI:84363


subject: CHEBI:84363


subject: CHEBI:84363


subject: CHEBI:84363


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin


subject: PUBCHEM.COMPOUND:11306691


subject: PUBCHEM.COMPOUND:11306691


subject: PUBCHEM.COMPOUND:11306691


subject: PUBCHEM.COMPOUND:11306691


subject: PUBCHEM.COMPOUND:11306691


subject: PUBCHEM.COMPOUND:11306691


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:53233

subject_name: thiazolyl blue


subject: CHEBI:53233


subject: CHEBI:53233


subject: CHEBI:53233


subject: CHEBI:53233


subject: CHEBI:53233


subject: CHEBI:53233


subject: PUBCHEM.COMPOUND:131613


subject: PUBCHEM.COMPOUND:131613


subject: PUBCHEM.COMPOUND:131613


subject: PUBCHEM.COMPOUND:131613


subject: PUBCHEM.COMPOUND:131613


subject: PUBCHEM.COMPOUND:131613


subject: PUBCHEM.COMPOUND:131613


subject: CHEBI:72313

subject_name: pasireotide aspartate


subject: CHEBI:72313


subject: CHEBI:72313


subject: CHEBI:72313


subject: CHEBI:72313


subject: CHEBI:72313


subject: CHEBI:72313


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide


subject: PUBCHEM.COMPOUND:11332179


subject: PUBCHEM.COMPOUND:11332179


subject: PUBCHEM.COMPOUND:11332179


subject: PUBCHEM.COMPOUND:11332179


subject: PUBCHEM.COMPOUND:11332179


subject: PUBCHEM.COMPOUND:11332179


subject: CHEBI:77733

subject_name: Verapamil


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:77733


subject: CHEBI:77733


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE


subject: PUBCHEM.COMPOUND:155543961


subject: PUBCHEM.COMPOUND:155543961


subject: PUBCHEM.COMPOUND:155543961


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: HER2 positive breast carcinoma


subject: GTOPDB:13716

subject_name: disitamab vedotin


subject: GTOPDB:13716

object_name: Her2-receptor negative breast cancer


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UNII:RB3U3A1S27


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib


subject: UNII:7B2CS922HI

subject_name: DANICAMTIV

object_name: Heart failure with reduced ejection fraction


subject: DRUGBANK:DB18962

subject_name: Danicamtiv


subject: CHEBI:6931

subject_name: Midazolam


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: endometrium neoplasm


subject: UMLS:C4287697


subject: CHEBI:177406

subject_name: CDDO-Me

object_name: pancreatic neoplasm


subject: CHEBI:177406

object_name: exocrine pancreatic carcinoma


subject: CHEBI:177406

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:53315588


subject: PUBCHEM.COMPOUND:53315588


subject: PUBCHEM.COMPOUND:53315588


subject: CHEBI:7726

subject_name: octreotide

object_name: thymoma


subject: CHEBI:7726

object_name: thymus neoplasm


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: central nervous system cancer


subject: CHEBI:175901

object_name: medulloblastoma


subject: CHEBI:175901

object_name: childhood medulloblastoma


subject: CHEBI:175901

object_name: adult medulloblastoma


subject: CHEBI:175901

object_name: Childhood Neuroblastoma


subject: CHEBI:175901

object_name: neuroblastoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805

object_name: pediatric osteosarcoma


subject: PUBCHEM.COMPOUND:43805

object_name: Osteosarcoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: Anorexia


subject: CHEBI:84094

subject_name: testosterone sulfate


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: postoperative cardiorespiratory failure


subject: PUBCHEM.COMPOUND:24846132

subject_name: Hetastarch


subject: DRUGBANK:DB09106

subject_name: hetastarch


subject: UMLS:C0976151

object_name: thyroid tumor


subject: UMLS:C0976151

object_name: thyroid gland carcinoma


subject: UMLS:C0976151

object_name: thyroid cancer


subject: UMLS:C0976151

object_name: familial congenital nasolacrimal duct obstruction


subject: UMLS:C0976151

object_name: lacrimal duct obstruction


subject: CHEBI:71219

subject_name: Pazopanib

object_name: non-small cell lung carcinoma


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: hemophagocytic syndrome


subject: UMLS:C0699319

object_name: familial hemophagocytic lymphohistiocytosis type 1


subject: UMLS:C0699319


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4315

subject_name: Danazol

object_name: breast fibrocystic disease


subject: UMLS:C1948466

subject_name: Petiveria alliacea preparation

object_name: acute leukemia


subject: UMLS:C1948466

object_name: acute leukemia in relapse


subject: UMLS:C1948466

object_name: acute lymphoblastic leukemia


subject: UMLS:C1948466

object_name: Relapsing acute myeloid leukemia


subject: UMLS:C1948466

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C1948466

object_name: acute myeloid leukemia


subject: UMLS:C1948466

object_name: gastric neoplasm


subject: UMLS:C1948466

object_name: pancreatic neoplasm


subject: UMLS:C1948466

object_name: Gastric neoplasms malignant


subject: UMLS:C1948466

object_name: colorectal neoplasm


subject: UNII:TQ0A9FIV71

subject_name: Inarigivir

object_name: Medication interaction potentiation


subject: UMLS:C3714646

subject_name: Neurobion

object_name: burning mouth syndrome


subject: PUBCHEM.COMPOUND:43805

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: pediatric lymphoma


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:17925

subject_name: alpha-D-glucose

object_name: interstitial cystitis


subject: CHEBI:17925

object_name: Painful Bladder Syndrome


subject: PUBCHEM.COMPOUND:24749

subject_name: Polyglucose


subject: PUBCHEM.COMPOUND:24749


subject: CHEBI:17634

subject_name: D-glucose


subject: CHEBI:17634


subject: CHEBI:17234


subject: CHEBI:17234


subject: UMLS:C0962969

subject_name: RAD 001

object_name: renal carcinoma


subject: UMLS:C0962969

object_name: kidney neoplasm


subject: UMLS:C0962969

object_name: kidney cancer


subject: UMLS:C0006404

subject_name: Subutex

object_name: opiate dependence


subject: UMLS:C0006404

object_name: Opioid use, unspecified


subject: UMLS:C0006404

object_name: Buprenorphine dependence


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE


subject: PUBCHEM.COMPOUND:9848990


subject: UNII:56DL1J49LR

object_name: Adult Rhabdomyosarcoma


subject: UNII:56DL1J49LR

object_name: rhabdomyosarcoma


subject: UNII:56DL1J49LR

object_name: Childhood Rhabdomyosarcoma


subject: UNII:56DL1J49LR

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UNII:56DL1J49LR

object_name: Ewing sarcoma


subject: CHEMBL.COMPOUND:CHEMBL2109352

object_name: hairy cell leukemia


subject: UMLS:C0796473


subject: UMLS:C1268859

subject_name: Zinc supplement

object_name: clonic hemifacial spasm


subject: UMLS:C1268859

object_name: Hemifacial spasm


subject: UMLS:C1268859

object_name: blepharospasm


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: cellulitis on exam (physical finding)


subject: CHEBI:137262

subject_name: Leu-Asn-Ser

object_name: malaria


subject: UMLS:C2826139

object_name: cancer


subject: UMLS:C2826139

object_name: neoplasm


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:52172

object_name: Chronic myeloid leukemia in myeloid blast crisis


subject: CHEBI:27594

subject_name: Graphite

object_name: pouchitis


subject: PUBCHEM.COMPOUND:544190

object_name: pneumonia


subject: PUBCHEM.COMPOUND:544190

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:7798

subject_name: Oseltamivir


subject: CHEBI:7798


subject: GTOPDB:13497

subject_name: axatilimab

object_name: interstitial lung disease 1


subject: GTOPDB:13497

object_name: interstitial lung disease 2


subject: CHEMBL.COMPOUND:CHEMBL4594608

subject_name: AXATILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594608


subject: UMLS:C4733597


subject: UMLS:C4733597


subject: CHEBI:41423

subject_name: Celecoxib

object_name: juvenile idiopathic arthritis


subject: CHEBI:59527


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:46557

subject_name: Zoledronic acid

object_name: primary hyperparathyroidism


subject: PUBCHEM.COMPOUND:12814875

subject_name: Artenimol


subject: PUBCHEM.COMPOUND:456410


subject: PUBCHEM.COMPOUND:540327

subject_name: Dihydroartemisinin


subject: PUBCHEM.COMPOUND:65404

subject_name: fanasil, pyrimethamine drug combination


subject: UNII:19997EZ42I

subject_name: Ampreloxetine

object_name: Multifocal nodular oncocytic hyperplasia of salivary gland


subject: UNII:19997EZ42I

object_name: Neurogenic Orthostatic Hypotension


subject: UNII:IEU56G3J9C

subject_name: LANREOTIDE ACETATE

object_name: neuroendocrine neoplasm


subject: CHEBI:15366

subject_name: Acetic acid

object_name: lymphangioleiomyomatosis


subject: CHEBI:15366

object_name: lung lymphangioleiomyomatosis


subject: CHEBI:15366

object_name: tuberous sclerosis


subject: CHEBI:15366

object_name: situs inversus


subject: CHEBI:15366

object_name: tuberous sclerosis 1


subject: UMLS:C0796512

subject_name: CCI 779

object_name: renal cell carcinoma


subject: UMLS:C0796512

object_name: kidney neoplasm


subject: UMLS:C0796512

object_name: kidney cancer


subject: CHEMBL.COMPOUND:CHEMBL2108506

subject_name: INTERFERON ALFA


subject: CHEMBL.COMPOUND:CHEMBL2108506


subject: CHEMBL.COMPOUND:CHEMBL2108506


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b


subject: UNII:43K1W2T1M6


subject: UMLS:C0043112

subject_name: WELL-FERON


subject: UMLS:C0043112


subject: UMLS:C0043112


subject: UMLS:C0751598

subject_name: Alferon


subject: UMLS:C0751598


subject: UMLS:C0751598


subject: UMLS:C2825023

subject_name: Interferon alpha [EPC]


subject: UMLS:C2825023


subject: UMLS:C2825023


subject: UNII:5QS67N4551

subject_name: Conestat alfa

object_name: Coronavinae infectious disease


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Diastolic dysfunction


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: asthma


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Anorexia


subject: CHEBI:74705

object_name: Anorexia, CTCAE


subject: CHEBI:74705

object_name: Anorexia symptom


subject: CHEBI:74705

object_name: Cachexia


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:10023

subject_name: Voriconazole

object_name: leukopenia


subject: CHEBI:10023

object_name: neutropenia


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:1805

object_name: head and neck squamous cell carcinoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: UMLS:C5203275

subject_name: Pralatrexate Liquid Injection

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C2959279

subject_name: Injection, pralatrexate, 1 mg


subject: CHEBI:71223

subject_name: Pralatrexate


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: facioscapulohumeral muscular dystrophy 2


subject: UNII:9603LN7R2Q

object_name: facioscapulohumeral muscular dystrophy 1


subject: UNII:9603LN7R2Q

object_name: facioscapulohumeral muscular dystrophy


subject: CHEBI:16919

subject_name: Creatine


subject: CHEBI:16919


subject: CHEBI:16919


subject: PUBCHEM.COMPOUND:3035406

subject_name: Caspofungin

object_name: candidemia


subject: CHEBI:31348

subject_name: Capecitabine

object_name: hypopharyngeal carcinoma


subject: CHEBI:4672

subject_name: Docetaxel


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole


subject: PUBCHEM.COMPOUND:147912


subject: UNII:C5529G5JPQ

subject_name: ginger extract

object_name: Xerostomia


subject: CHEBI:90677

object_name: cancer


subject: CHEBI:90677

object_name: neoplasm


subject: UMLS:C2347443


subject: UMLS:C2347443


subject: CHEBI:64220

subject_name: monosodium glutamate

object_name: Cognitive impairment


subject: CHEBI:64220

object_name: Stress


subject: CHEBI:16015

subject_name: Glutamic acid


subject: CHEBI:16015


subject: UMLS:C0037511

subject_name: sodium glutamate


subject: UMLS:C0037511


subject: PR:000022772

subject_name: malate synthase G


subject: PR:000022772


subject: CHEBI:91872

object_name: Advanced Hodgkin Lymphoma


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UNII:7XL5ISS668

subject_name: Adcetris


subject: UMLS:C1832035


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4305

subject_name: dacarbazine


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:27375

subject_name: Vinblastine


subject: MESH:C576777

subject_name: tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine

object_name: Invasive meningococcal disease


subject: UNII:R7O0O4110G


subject: UNII:R7O0O4110G


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Klinefelter syndrome


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: PUBCHEM.COMPOUND:54681908

subject_name: Sarecycline

object_name: acne


subject: PUBCHEM.COMPOUND:71296095

subject_name: Sarecycline Hydrochloride


subject: MESH:C000613148

object_name: Prediabetes


subject: UMLS:C3892043

subject_name: Ibuprofen Injection

object_name: Fever


subject: UMLS:C3892043

object_name: Fever symptoms (finding)


subject: UMLS:C3892043

object_name: Fever, CTCAE


subject: CHEBI:9434

subject_name: Telmisartan

object_name: essential hypertension


subject: UMLS:C2980817

subject_name: Morinda citrifolia fruit extract

object_name: prostate carcinoma


subject: UMLS:C2980817

object_name: prostate cancer


subject: UNII:ULS5I8J03O

subject_name: Olsalazine

object_name: ankylosing spondylitis


subject: GTOPDB:5015

subject_name: leptin

object_name: HIV lipodystrophy


subject: CHEBI:81571

subject_name: Leptin


subject: UMLS:C3535635

subject_name: leptin human


subject: CHEBI:135673

subject_name: Rupatadine

object_name: rheumatoid arthritis


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Angina pectoris


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: thymoma


subject: CHEBI:6888

object_name: thymus neoplasm


subject: UNII:4X4HLN92OT

subject_name: Tribulus terrestris

object_name: Female sexual arousal disorder


subject: UMLS:C1959634

subject_name: Extra Strength Acetaminophen

object_name: arthritis


subject: UMLS:C1959634

object_name: Arthritis, CTCAE


subject: UMLS:C1959634

object_name: Cognitive impairment


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:85989

subject_name: Avycaz

object_name: Hospital acquired pneumonia


subject: UMLS:C3656596

subject_name: avibactam / ceftazidime


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: neoplasm of esophagus


subject: CHEBI:68646

object_name: gastric neoplasm


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:76842

object_name: Infection


subject: CHEBI:76842

object_name: infectious disease


subject: CHEBI:76842

object_name: Adverse Event Associated with Infection


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: CHEBI:28001


subject: UNII:T60AV22R32

subject_name: Chlorazine

object_name: delirium


subject: UNII:T60AV22R32

object_name: Delirium, CTCAE


subject: UNII:T60AV22R32

object_name: Embolism, Tumor


subject: UNII:T60AV22R32

object_name: Advanced cancer


subject: UNII:T60AV22R32

object_name: Recurrent Malignant Neoplasm


subject: UNII:T60AV22R32

object_name: Locally Advanced Malignant Neoplasm


subject: CHEBI:3647

subject_name: Chlorpromazine


subject: CHEBI:3647


subject: CHEBI:3647


subject: CHEBI:3647


subject: CHEBI:3647


subject: CHEBI:3647


subject: CHEBI:5613

subject_name: Haloperidol


subject: CHEBI:5613


subject: CHEBI:5613


subject: CHEBI:5613


subject: UMLS:C5908004

subject_name: Anti-CD123/TOP1i Antibody-drug Conjugate AZD9829

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: hyperlipidemia


subject: UNII:PP0SHH6V16

object_name: hyperlipoproteinemia


subject: UNII:PP0SHH6V16

object_name: Hyperlipidemia, CTCAE


subject: UNII:PP0SHH6V16

object_name: Serum lipids high (finding)


subject: CHEBI:5130

subject_name: Flurbiprofen

object_name: Hoarse voice


subject: CHEBI:5130

object_name: Hoarseness, CTCAE


subject: UMLS:C3660928

object_name: Childhood Breast Carcinoma


subject: UMLS:C3660928

object_name: breast carcinoma


subject: UMLS:C3660928

object_name: breast cancer


subject: UMLS:C5237726

subject_name: Anti-CD20 Monoclonal Antibody MIL62

object_name: neuromyelitis optica


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Insulin Sensitivity


subject: UMLS:C3491843

object_name: inborn mitochondrial metabolism disorder


subject: UMLS:C3491843

object_name: mitochondrial disease


subject: CHEBI:64073

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: acne


subject: CHEBI:18743

subject_name: (S)-2-trans-abscisic acid


subject: CHEBI:2365

subject_name: Abscisic Acid


subject: CHEBI:53554

subject_name: 4,4'-azodibenzenearsonic acid


subject: UNII:V5PC588N7G

subject_name: Mag 2 (TN)


subject: CHEBI:29999

subject_name: L-serine residue

object_name: amyotrophic lateral sclerosis


subject: CHEBI:17115

subject_name: Serine


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:31355

object_name: Recurrent Glioblastoma


subject: UMLS:C4279659

object_name: insomnia


subject: UMLS:C4279659

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C4279659

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Atopic dermatitis, severe


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UMLS:C4279629

subject_name: Xydalba

object_name: bacterial infectious disease


subject: PUBCHEM.COMPOUND:5148108

subject_name: Resiniferatoxin

object_name: Morton neuroma


subject: CHEBI:73609

subject_name: Met-Ala-Asp

object_name: hepatitis B


subject: MESH:C110804

subject_name: mycophenolic adenine dinucleotide


subject: GTOPDB:13086

subject_name: efanesoctocog alfa

object_name: hemophilia A


subject: UNII:WH7BHQ0RB4

subject_name: EFANESOCTOCOG ALFA


subject: MESH:C501366

subject_name: DermaVir

object_name: HIV infection


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Ischemic stroke


subject: CHEBI:134024

subject_name: chlorofluorocarbon


subject: PR:000016127

subject_name: tubulin-specific chaperone C


subject: CHEBI:33216

subject_name: Bisphenol A


subject: PR:000031275

subject_name: dystonin


subject: UMLS:C4723703

subject_name: boron phenylalanine


subject: UNII:P5DKZ70636

subject_name: Paxalisib

object_name: adult glioblastoma


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Childhood Solid Neoplasm


subject: UNII:3A189DH42V

object_name: Adult Solid Neoplasm


subject: UNII:3A189DH42V

object_name: Solid Neoplasm


subject: UNII:3A189DH42V

object_name: neuroepithelial neoplasm


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:201431


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C0064294

subject_name: fibroblast growth factor 7


subject: UMLS:C0064294


subject: UMLS:C0064294


subject: UMLS:C0064294


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:58097

object_name: Idiopathic scoliosis and kyphoscoliosis


subject: CHEBI:58097

object_name: idiopathic scoliosis


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: UNII:DB1041CXDG

subject_name: BELANTAMAB

object_name: AL amyloidosis


subject: UMLS:C3826989


subject: CHEBI:95341

subject_name: Baricitinib

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:45783

subject_name: Imatinib


subject: UNII:41XGO0VS1U

object_name: carcinoma


subject: UNII:41XGO0VS1U

object_name: digestive system neoplasm


subject: UNII:41XGO0VS1U

object_name: liver neoplasm


subject: UMLS:C5555135

subject_name: KRAS G12C Inhibitor D-1553


subject: UMLS:C5555135


subject: UMLS:C5555135


subject: UMLS:C5237721

subject_name: FAK1 Inhibitor IN10018


subject: UMLS:C5237721


subject: UMLS:C5237721


subject: CHEBI:44915

subject_name: Propofol

object_name: cerebral palsy


subject: CHEBI:232390

object_name: pancreatitis


subject: CHEBI:232390

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:232390

object_name: Pancreatitis, CTCAE 3.0


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Traumatic hemorrhage


subject: UMLS:C5139939

object_name: hemophilia A


subject: CHEBI:187893

subject_name: Baclofen

object_name: morbid obesity


subject: CHEBI:187893

object_name: post operative nausea and vomiting


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: peritoneal carcinomatosis


subject: CHEBI:27504

subject_name: Mitomycin


subject: UNII:8M7YSN2KII

subject_name: nortramadol


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: CHEMBL.COMPOUND:CHEMBL4594569

subject_name: AMLITELIMAB

object_name: celiac disease


subject: UMLS:C5555444

subject_name: Amlitelimab


subject: UMLS:C1744513

object_name: myeloid leukemia


subject: UMLS:C3650126

subject_name: azilsartan medoxomil + chlorthalidone

object_name: essential hypertension


subject: UMLS:C0038889

subject_name: Endogenous Surfactants

object_name: Premature birth


subject: UMLS:C0038889

object_name: premature birth (history)


subject: CHEBI:35195

subject_name: surfactant


subject: CHEBI:35195


subject: UMLS:C2825078

subject_name: Surfactant [EPC]


subject: UMLS:C2825078


subject: CHEBI:230352

subject_name: Desidustat

object_name: Effects of chemotherapy


subject: CHEBI:230352

object_name: Anemia in chronic kidney disease


subject: UMLS:C5198569

subject_name: desidustat


subject: UMLS:C5198569


subject: CHEBI:135552

subject_name: Prucalopride

object_name: bladder tumor


subject: CHEBI:135552

object_name: urinary bladder carcinoma


subject: CHEBI:135552

object_name: urinary bladder cancer


subject: CHEBI:135552

object_name: childhood bladder carcinoma


subject: UNII:09495UIM6V

subject_name: Bimekizumab

object_name: Axial Spondyloarthritis


subject: UNII:09495UIM6V


subject: UNII:09495UIM6V

object_name: ankylosing spondylitis


subject: CHEBI:47898

subject_name: Epirubicin

object_name: triple-negative breast carcinoma


subject: CHEBI:47898

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: relapsing polychondritis


subject: PUBCHEM.COMPOUND:76470875

subject_name: Glecaprevir

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:76470875

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:76668718

subject_name: Pibrentasvir


subject: PUBCHEM.COMPOUND:76668718


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: lung cancer


subject: HMDB:HMDB0001349

object_name: lung neoplasm


subject: HMDB:HMDB0001349

object_name: lung carcinoma


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: UMLS:C0521939


subject: UniProtKB:P47737

subject_name: X19F_ECOLI X polypeptide (sprot)

object_name: B-cell non-Hodgkin lymphoma


subject: UniProtKB:P47737

object_name: B-cell neoplasm


subject: UniProtKB:P47737

object_name: large B-cell lymphoma


subject: UniProtKB:P47737

object_name: primary mediastinal large B-cell lymphoma


subject: UniProtKB:P47737

object_name: high grade B-cell lymphoma


subject: UniProtKB:P47737

object_name: Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Molecular Subtypes


subject: CHEBI:35430

subject_name: DIIODOTHYRONINE


subject: CHEBI:35430


subject: CHEBI:35430


subject: CHEBI:35430


subject: CHEBI:35430


subject: CHEBI:35430


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:29298

subject_name: ditritium


subject: CHEBI:29298


subject: CHEBI:29298


subject: CHEBI:29298


subject: CHEBI:29298


subject: CHEBI:29298


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: UniProtKB:Q06666

subject_name: T2_MOUSE Octapeptide-repeat protein T2 (sprot)


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: PR:000034234

subject_name: octapeptide-repeat protein T2


subject: PR:000034234


subject: PR:000034234


subject: PR:000034234


subject: PR:000034234


subject: PR:000034234


subject: UNII:01F4FRP8YL

subject_name: mirogabalin

object_name: Post-Operative Pain


subject: UNII:01F4FRP8YL

object_name: osteoarthritis


subject: PUBCHEM.COMPOUND:66696998

subject_name: Mirogabalin


subject: PUBCHEM.COMPOUND:66696998


subject: CHEBI:16526

subject_name: Carbon dioxide

object_name: abdominal aortic aneurysm


subject: CHEBI:16526

object_name: Critical lower limb ischemia


subject: CHEBI:63632

subject_name: Topotecan

object_name: vulva cancer


subject: CHEBI:63632

object_name: vulva carcinoma


subject: CHEBI:63632

object_name: vaginal cancer


subject: CHEBI:63632

object_name: vaginal carcinoma


subject: CHEBI:63632

object_name: cervical cancer


subject: CHEBI:63632

object_name: cervical carcinoma


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Solid Neoplasm


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: pancreatic neoplasm


subject: CHEBI:66919

object_name: exocrine pancreatic carcinoma


subject: CHEBI:66919

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: suppressor of tumorigenicity 3


subject: CHEBI:681569

subject_name: Clofarabine

object_name: leukemia, acute lymphocytic, susceptibility to, 1


subject: CHEBI:681569

object_name: lymphoblastic leukemia, acute, with lymphomatous features


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: UNII:7Y4N11PXO8

subject_name: Troxerutin

object_name: Inflammation


subject: CHEBI:72544

subject_name: flavonoids


subject: CHEBI:47916

subject_name: flavonoid


subject: UMLS:C3827044

subject_name: Toca FC

object_name: adult lymphoma


subject: UMLS:C3827044

object_name: lymphoma


subject: UMLS:C3827044

object_name: pediatric lymphoma


subject: UMLS:C3827044

object_name: triple-negative breast carcinoma


subject: UMLS:C3827044

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C3827044

object_name: Neck Carcinoma


subject: UMLS:C3827044

object_name: head and neck neoplasm


subject: UMLS:C3827044

object_name: head and neck cancer


subject: UMLS:C3827044

object_name: non-small cell lung carcinoma


subject: UMLS:C3827044


subject: UMLS:C3827044


subject: UMLS:C3827044


subject: UMLS:C3827044

object_name: ovarian cancer


subject: UMLS:C3827044

object_name: ovarian neoplasm


subject: UMLS:C3827044

object_name: ovarian carcinoma


subject: UMLS:C3827044

object_name: colorectal cancer


subject: UMLS:C3827044

object_name: colorectal carcinoma


subject: UMLS:C3827044

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3827044

object_name: melanoma


subject: UMLS:C3827044

object_name: malignant soft tissue neoplasm


subject: UMLS:C3827044

object_name: sarcoma


subject: UMLS:C1971342

subject_name: Injection, protein c concentrate, intravenous, human, 10 iu

object_name: hereditary thrombophilia due to congenital protein C deficiency


subject: UMLS:C0033621

subject_name: protein C


subject: UMLS:C3854178

subject_name: PROTEIN C CONCENTRATE


subject: PUBCHEM.COMPOUND:333445

subject_name: RL

object_name: kernicterus


subject: CHEBI:73815

subject_name: Arg-Leu


subject: UMLS:C0034131

subject_name: Tubersol

object_name: latent tuberculosis infection


subject: UMLS:C2958914

subject_name: INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT

object_name: Functional Status


subject: UMLS:C2958914

object_name: Function Axis


subject: UMLS:C2958914

object_name: Bilateral plantar fasciitis


subject: CHEBI:31485

subject_name: Difluprednate

object_name: Inflammation


subject: CHEBI:133146

subject_name: Phe-Ala

object_name: Post-Operative Pain


subject: CHEBI:39002

subject_name: perfluoroadamantane


subject: CHEBI:29013

subject_name: Fusidic acid


subject: CHEBI:27470

subject_name: Folic acid


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Mass of soft tissue


subject: CHEBI:3215

object_name: musculoskeletal system disorder


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918


subject: CHEBI:3757

subject_name: Clonidine


subject: CHEBI:3757


subject: CHEBI:25357

subject_name: mitomycin

object_name: Unresectable Colorectal Carcinoma


subject: CHEBI:25357

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: CHEBI:25357

object_name: Metastatic Appendix Carcinoma


subject: CHEBI:25357

object_name: Metastatic Colorectal Carcinoma


subject: CHEBI:25357

object_name: Metastatic malignant neoplasm to peritoneum


subject: CHEBI:25357

object_name: Stage IV Appendix Carcinoma AJCC v8


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:31355

subject_name: Carboplatin

object_name: ovarian clear cell cystadenocarcinoma


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Ovarian cancer stage III


subject: CHEBI:4672

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:4672

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:4672

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:4672

object_name: Ovarian cancer stage IV


subject: CHEBI:4672


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: liver cancer


subject: PUBCHEM.COMPOUND:2767

object_name: liver neoplasm


subject: PUBCHEM.COMPOUND:2767

object_name: Adult Liver Carcinoma


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:64816

object_name: Embolism, Tumor


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357

object_name: liver carcinoma


subject: CHEBI:25357


subject: CHEBI:27504


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: neuroendocrine carcinoma


subject: GTOPDB:13796

subject_name: serplulimab


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C4745029

subject_name: HLX 10


subject: UMLS:C0939309

subject_name: Depakote ER

object_name: bipolar disorder


subject: UMLS:C0538777

subject_name: ancestim

object_name: plasma cell myeloma


subject: UMLS:C2985191

object_name: Solid Neoplasm


subject: UMLS:C2985191

object_name: Neck Carcinoma


subject: UMLS:C2985191

object_name: head and neck neoplasm


subject: UMLS:C2985191

object_name: head and neck cancer


subject: UMLS:C2985191

object_name: lung cancer


subject: UMLS:C2985191

object_name: lung neoplasm


subject: UMLS:C2985191

object_name: lung carcinoma


subject: UMLS:C2347906

subject_name: Anpocogin

object_name: colon carcinoma


subject: UMLS:C2347906

object_name: colorectal cancer


subject: UMLS:C2347906

object_name: colon cancer


subject: UMLS:C5432265

subject_name: Goflikicept

object_name: Primary gout


subject: UMLS:C5432265

object_name: Gout attack


subject: CHEBI:145371

subject_name: Binimetinib

object_name: low grade glioma


subject: CHEBI:145371

object_name: pancreatic neoplasm


subject: CHEBI:145371

object_name: malignant pancreatic neoplasm


subject: UNII:65V47O9NOP

object_name: narcolepsy


subject: CHEBI:36704

subject_name: Imiquimod

object_name: vulvar intraepithelial neoplasia


subject: UMLS:C2703096


subject: CHEBI:60775

subject_name: Verteporfin

object_name: central serous chorioretinopathy


subject: CHEMBL.COMPOUND:CHEMBL5314346

subject_name: VERTEPORFIN


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: acute kidney failure


subject: CHEBI:38290

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: Allergy to nalbuphine


subject: UMLS:C2980570

subject_name: spinosad topical

object_name: scabies


subject: UMLS:C0354604

subject_name: oral anticoagulants

object_name: venous thromboembolism


subject: UMLS:C0354604

object_name: thrombophilia due to thrombin defect


subject: UMLS:C0354604

object_name: Anticoagulants and Bleeding Disorders


subject: CHEBI:132922

object_name: Prematurity of fetus


subject: CHEBI:132922

object_name: bronchopulmonary dysplasia


subject: CHEBI:132922

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: CHEBI:46195


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: COPD, severe early onset


subject: UMLS:C0812735

object_name: chronic obstructive pulmonary disease


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Drug Resistant Epilepsy


subject: UMLS:C1138321

subject_name: glutoxim

object_name: Myelodysplasia


subject: UMLS:C1138321

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C1138321

object_name: childhood myelodysplastic syndrome


subject: UMLS:C1138321

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C1138321

object_name: leukemia


subject: UMLS:C1138321

object_name: childhood leukemia


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: gastroesophageal cancer


subject: CHEBI:151

subject_name: ISOCITRIC ACID


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: MIT family translocation renal cell carcinoma


subject: CHEBI:72317

object_name: collecting duct carcinoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: papillary renal cell carcinoma


subject: CHEBI:231679


subject: CHEBI:231679

object_name: chromophobe renal cell carcinoma


subject: CHEBI:231679

object_name: Unclassified Renal Cell Carcinoma


subject: CHEBI:231679

object_name: Renal Cell Carcinoma, Not Otherwise Specified


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: prostate disorder


subject: CHEBI:63605

object_name: male reproductive system disorder


subject: CHEBI:63605

object_name: prostate neoplasm


subject: CHEBI:63605

object_name: Epithelioma


subject: CHEBI:63605

object_name: male reproductive system neoplasm


subject: CHEBI:63605

object_name: male reproductive organ cancer


subject: CHEBI:63605

object_name: Neoplasm of the genitourinary tract


subject: CHEBI:63605

object_name: esophageal adenocarcinoma


subject: CHEBI:63605

object_name: lung adenocarcinoma


subject: CHEBI:63605

object_name: adenocarcinoma


subject: CHEBI:63605

object_name: bile duct adenocarcinoma


subject: CHEBI:63605

object_name: gastric adenocarcinoma


subject: CHEBI:63605

object_name: carcinoma


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: sickle cell disease


subject: UNII:7D0YB67S97

object_name: chronic granulomatous disease


subject: UNII:7D0YB67S97

object_name: hemophagocytic syndrome


subject: UNII:7D0YB67S97

object_name: Leukocyte adhesion deficiency


subject: UNII:7D0YB67S97

object_name: leukocyte adhesion deficiency 1


subject: UNII:7D0YB67S97

object_name: severe congenital neutropenia


subject: UNII:7D0YB67S97

object_name: Shwachman-Diamond syndrome


subject: UNII:7D0YB67S97

object_name: Shwachman-Diamond syndrome 1


subject: UNII:7D0YB67S97

object_name: Severe Aplastic Anemia


subject: UNII:7D0YB67S97

object_name: severe aplastic anemia


subject: UNII:7D0YB67S97

object_name: Diamond-Blackfan anemia


subject: UNII:7D0YB67S97

object_name: Aase syndrome


subject: UNII:7D0YB67S97

object_name: Thrombasthenia


subject: UNII:7D0YB67S97

object_name: Chediak-Higashi syndrome


subject: UNII:7D0YB67S97

object_name: Wiskott-Aldrich syndrome


subject: UNII:7D0YB67S97

object_name: Cooley's anemia


subject: UNII:7D0YB67S97

object_name: beta thalassemia


subject: UNII:7D0YB67S97

object_name: mucopolysaccharidosis type 1


subject: UNII:7D0YB67S97

object_name: Hurler syndrome


subject: UNII:7D0YB67S97

object_name: Fanconi anemia


subject: UNII:7D0YB67S97

object_name: Fanconi anemia complementation group A


subject: UMLS:C0378942

object_name: sickle cell disease


subject: UMLS:C0378942

object_name: chronic granulomatous disease


subject: UMLS:C0378942

object_name: hemophagocytic syndrome


subject: UMLS:C0378942

object_name: Leukocyte adhesion deficiency


subject: UMLS:C0378942

object_name: leukocyte adhesion deficiency 1


subject: UMLS:C0378942

object_name: severe congenital neutropenia


subject: UMLS:C0378942

object_name: Shwachman-Diamond syndrome


subject: UMLS:C0378942

object_name: Shwachman-Diamond syndrome 1


subject: UMLS:C0378942

object_name: Severe Aplastic Anemia


subject: UMLS:C0378942

object_name: severe aplastic anemia


subject: UMLS:C0378942

object_name: Diamond-Blackfan anemia


subject: UMLS:C0378942

object_name: Aase syndrome


subject: UMLS:C0378942

object_name: Thrombasthenia


subject: UMLS:C0378942

object_name: Chediak-Higashi syndrome


subject: UMLS:C0378942

object_name: Wiskott-Aldrich syndrome


subject: UMLS:C0378942

object_name: Cooley's anemia


subject: UMLS:C0378942

object_name: beta thalassemia


subject: UMLS:C0378942

object_name: mucopolysaccharidosis type 1


subject: UMLS:C0378942

object_name: Hurler syndrome


subject: UMLS:C0378942

object_name: Fanconi anemia


subject: UMLS:C0378942

object_name: Fanconi anemia complementation group A


subject: GTOPDB:13611

subject_name: patisiran

object_name: hereditary amyloidosis


subject: GTOPDB:13611

object_name: Amyloid Neuropathies


subject: UNII:50FKX8CB2Y

subject_name: Patisiran


subject: UNII:50FKX8CB2Y


subject: UMLS:C3896921


subject: UMLS:C3896921

object_name: amyloidosis, hereditary systemic 1


subject: UMLS:C3896921

object_name: familial amyloid neuropathy


subject: UMLS:C3896921


subject: PUBCHEM.COMPOUND:18762634

subject_name: Avanafil

object_name: impotence


subject: PUBCHEM.COMPOUND:18762634

object_name: Erectile Dysfunction, CTCAE


subject: PUBCHEM.COMPOUND:18762634

object_name: Erectile dysfunction


subject: UNII:V5Y646AW8S

object_name: cancer


subject: UNII:V5Y646AW8S

object_name: neoplasm


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:2618


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:6538


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: dyspepsia


subject: CHEBI:50275

object_name: Dyspepsia, CTCAE


subject: CHEBI:50275

object_name: digestive system disorder


subject: CHEBI:50275

object_name: gastrointestinal disease


subject: CHEBI:50275

object_name: Digestive System Signs and Symptoms


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: CHEBI:77260


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: Abdominal pain


subject: CHEBI:9667

object_name: Abdominal Pain, CTCAE


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: helminthiasis


subject: PUBCHEM.COMPOUND:6427057

object_name: Infection by Strongyloides stercoralis


subject: CHEBI:6078

subject_name: Ivermectin


subject: CHEBI:6078


subject: CHEBI:16664

subject_name: Albendazole


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Prediabetes


subject: CHEBI:30314

object_name: glucose intolerance


subject: CHEBI:30314

object_name: Impaired glucose tolerance


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: CHEBI:16494


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:31932

subject_name: olmesartan


subject: CHEBI:31932


subject: CHEBI:31932


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:91951


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: precocious puberty


subject: UMLS:C1518041

object_name: Precocious Puberty, CTCAE 5.0


subject: CHEBI:84363

object_name: Androgen excess


subject: UMLS:C4723695

subject_name: penpulimab

object_name: squamous cell lung carcinoma


subject: UMLS:C4723695

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:28911

subject_name: cob(III)alamin

object_name: premature ejaculation


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: PUBCHEM.COMPOUND:16681698

subject_name: Obatoclax mesylate

object_name: follicular lymphoma


subject: CHEBI:94522


subject: UNII:39200FJ43J

subject_name: [OBSOLETE] obatoclax mesylate


subject: UMLS:C1831948

subject_name: obatoclax mesylate


subject: CHEBI:7457

subject_name: Nalmefene

object_name: Behavioural addiction


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Advanced Sarcoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:91996

subject_name: Dihydrexidine

object_name: cocaine abuse


subject: CHEBI:124993


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: Fatty acid deficiency


subject: UNII:71M78END5S

object_name: schizophrenia


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: PR:000001026

subject_name: lymphocyte antigen 75

object_name: Metastatic Renal Cell Carcinoma


subject: PR:000001026

object_name: Metastatic Renal Cell Cancer


subject: PR:000001026

object_name: Stage IV Prostate Cancer AJCC v6


subject: PR:000001026

object_name: Carcinoma of the prostate stage IV


subject: PR:000001026

object_name: Stage IV Prostate Cancer AJCC v7


subject: PR:000001026

object_name: Stage IV Prostate Cancer AJCC v8


subject: PR:000001026

object_name: hormone-resistant prostate carcinoma


subject: PR:000001026

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: PR:000001026

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: PR:000001026

object_name: Stage IA Breast Cancer AJCC v7


subject: PR:000001026

object_name: stage IA breast cancer


subject: PR:000001026

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: PR:000001026

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: PR:000001026

object_name: Stage IB Breast Cancer AJCC v7


subject: PR:000001026

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: PR:000001026

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: PR:000001026

object_name: Stage IIA Breast Carcinoma


subject: PR:000001026

object_name: Stage IC Ovarian Cancer AJCC v6 and v7


subject: PR:000001026

object_name: Stage IC Ovarian Cancer AJCC v8


subject: PR:000001026

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: PR:000001026

object_name: Stage IV Ovarian Cancer AJCC v8


subject: PR:000001026

object_name: Ovarian cancer stage IV


subject: PR:000001026

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: PR:000001026

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: PR:000001026

object_name: Stage IIB Breast Carcinoma


subject: PR:000001026

object_name: malignant neoplasm of breast stage IIb


subject: PR:000001026

object_name: Stage IB Ovarian Cancer AJCC v6 and v7